Seres Therapeutics Inc Share Price Today: Live Updates & Key Insights
Seres Therapeutics Inc share price today is $8.67, up -6.39%. The stock opened at $8.65 against the previous close of $9.08, with an intraday high of $8.89 and low of $8.44.
Seres Therapeutics Inc Share Price Chart
Seres Therapeutics Inc
Seres Therapeutics Inc Share Price Performance
Seres Therapeutics Inc Institutional Holdings
Seres Therapeutics Inc Market Status
Seres Therapeutics Inc Fundamentals
Market Cap 76.90 M
PB Ratio 1.7639
PE Ratio 9.6591
Enterprise Value 114.69 M
Total Assets 138.19 M
Volume 84803
Seres Therapeutics Inc Company Financials
About Seres Therapeutics Inc & investment objective
Company Information Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 66
Industry Biotechnology
CEO Mr. Richard N. Kender B.S., M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Seres Therapeutics Inc FAQs
What is the share price of Seres Therapeutics Inc today?
The current share price of Seres Therapeutics Inc is $8.67.
Can I buy Seres Therapeutics Inc shares in India?
Yes, Indian investors can buy Seres Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Seres Therapeutics Inc shares in India?
You can easily invest in Seres Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Seres Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Seres Therapeutics Inc.
Can I buy fractional shares of Seres Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Seres Therapeutics Inc?
Seres Therapeutics Inc has a market cap of $76.90 M.
In which sector does Seres Therapeutics Inc belong?
Seres Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Seres Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Seres Therapeutics Inc?
The PE ratio of Seres Therapeutics Inc is 9.66 and the PB ratio is 1.76.